Paul Bury resumes & CV records
Resumes
Paul Bury
Paul Bury
Paul R Bury
Paul R Bury
Paul A Bury, 542802 Trinity Loop, Westminster, CO 80023
Paul Bury Phones & Addresses
2802 Trinity Loop, Broomfield, CO 80023 303-8425181
Westminster, CO
1232 Shelter Creek Ln, San Bruno, CA 94066
5117 Shelter Creek Ln, San Bruno, CA 94066
5332 Shelter Creek Ln, San Bruno, CA 94066
9843 Vine St, Denver, CO 80229 303-9552039 720-8720207 303-8720207
13720 Alaska Ave, Denver, CO 80228 303-9872118
Northglenn, CO
Belmont, CA
San Mateo, CA
Concord, CA
Mentions for Paul A Bury
Publications & IP owners
Us Patents
Insulinotropic Peptide Synthesis Using Solid And Solution Phase Combination Techniques
US Patent:
8378066, Feb 19, 2013
Filed:
Oct 24, 2008
Appl. No.:
12/288934
Inventors:
Barry Thomas King - Boulder CO, US
Paul Adam Bury - Thornton CO, US
Richard A. Gabel - Louisville CO, US
John Edward Crider - Boulder CO, US
Bradley S. DeHoff - Longmont CO, US
Paul Adam Bury - Thornton CO, US
Richard A. Gabel - Louisville CO, US
John Edward Crider - Boulder CO, US
Bradley S. DeHoff - Longmont CO, US
Assignee:
Corden Pharma Colorado, Inc. - Boulder CO
International Classification:
C07K 7/06
C07K 7/08
C07K 14/46
C07K 14/605
C07K 7/08
C07K 14/46
C07K 14/605
US Classification:
530324, 530326, 530327, 530328, 530332, 530339, 530345
Abstract:
The present invention relates to the preparation of insulinotropic peptides that are synthesized using a solid and solution phase (“hybrid”) approach. Generally, the approach includes synthesizing three different peptide intermediate fragments using solid phase chemistry. Solution phase chemistry is then used to add additional amino acid material to one of the fragments. The fragments are then coupled together in the solution phase. The use of a pseudoproline in one of the fragments eases solid phase synthesis of that fragment and also eases subsequent solution phase coupling of this fragment to other fragments. The present invention is very useful for forming insulinotropic peptides such as Exenatide(1-39) and its natural and non-natural counterparts.
Nucleic Acid Array Preparation Using Purified Phosphoramidites
US Patent:
2003023, Dec 18, 2003
Filed:
Mar 27, 2003
Appl. No.:
10/402333
Inventors:
Dale Barone - San Jose CA, US
Glenn McGall - Mountain View CA, US
Mark Trulson - San Jose CA, US
Paul Bury - San Bruno CA, US
Robert Carroll - Mountain View CA, US
Glenn McGall - Mountain View CA, US
Mark Trulson - San Jose CA, US
Paul Bury - San Bruno CA, US
Robert Carroll - Mountain View CA, US
Assignee:
Affymetrix, Inc. - Santa Clara CA
International Classification:
C12Q001/68
B05D003/00
B05D003/00
US Classification:
435/006000, 427/002110
Abstract:
Improved nucleic acid arrays are provided which have been prepared using nucleoside phosphoramidites having reduced levels of interfering phosphoramidite impurities.
Oligonucleotide Synthesis With Intermittent And Post Synthetic Oxidation
US Patent:
2007025, Nov 1, 2007
Filed:
Jan 2, 2007
Appl. No.:
11/619046
Inventors:
Robert Kuimelis - Palo Alto CA, US
Paul Bury - Thornton CO, US
Paul Bury - Thornton CO, US
Assignee:
Affymetrix, INC. - Santa Clara CA
International Classification:
C07H 21/04
US Classification:
536025310
Abstract:
Process for fabricating an array of polymers on a solid support is provided having the steps of coupling a monomer with a reactive side masked by a protecting group to a growing polymer chain, optionally capping the monomer or monomer chains that have not reacted in a given cycle, deprotecting the product with a deprotecting agent, repeating the above steps on regions of the support as necessary to give polymers having a desired sequence and length and oxidizing the inter monomer linkage post-synthetically.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.